TachoSil®
TC-2402-040-SP
Phase 3 mab completed
Quick answer
TachoSil® for Hemorrhage is a Phase 3 program (mab) at Takeda with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda
- Indication
- Hemorrhage
- Phase
- Phase 3
- Modality
- mab
- Status
- completed